BRIEF published on 12/19/2025 at 07:35, 10 months 7 days ago Sensorion to Present at J.P. Morgan Healthcare Conference Biotechnology Gene Therapy J.P. Morgan Hearing Loss SENS-401
PRESS RELEASE published on 12/19/2025 at 07:30, 10 months 7 days ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à la 44ème conférence annuelle J.P. Morgan Healthcare Conference à San Francisco du 12 au 15 janvier 2026 pour présenter ses avancées en thérapies auditives Biotechnologie Conference J.P. Morgan Sensorion Thérapies Auditives
PRESS RELEASE published on 12/19/2025 at 07:30, 10 months 7 days ago Inside Information / Other news releases Sensorion to present at 44th Annual J.P. Morgan Healthcare Conference with focus on novel therapies for hearing loss disorders. CEO Nawal Ouzren to lead presentation Biotechnology Sensorion Hearing Loss Disorders J.P. Morgan Healthcare Conference Thérapies
BRIEF published on 09/17/2025 at 07:35, 1 year 1 month ago Sensorion annonce ses résultats semestriels 2025 Financement Thérapie Génique SENS-401 SENS-501 Résultats 2025
BRIEF published on 09/17/2025 at 07:35, 1 year 1 month ago Sensorion announces its 2025 half-year results Funding Gene Therapy SENS-401 SENS-501 2025 Results
PRESS RELEASE published on 09/17/2025 at 07:30, 1 year 1 month ago Informations privilégiées / Communiqué sur comptes, résultats Sensorion présente ses résultats du premier semestre 2025, activités de thérapie génique SENS-501, GJB2-GT et SENS-401, annonce dépôts réglementaires et études cliniques en cours Résultats Thérapie Génique Études Cliniques Dépôts Réglementaires Sensorion
PRESS RELEASE published on 09/17/2025 at 07:30, 1 year 1 month ago Inside Information / News release on accounts, results Sensorion reports 2025 half-year results, corporate update, and availability of half-year report. Progress in gene therapy programs for hearing loss disorders discussed Clinical Trials Gene Therapy Sensorion Hearing Loss Disorders 2025 Half-Year Results
BRIEF published on 09/04/2025 at 07:35, 1 year 1 month ago Sensorion to Present at 60th Inner Ear Biology Workshop Biotechnology Gene Therapy Sensorion Hearing Loss Inner Ear Biology Workshop
BRIEF published on 09/04/2025 at 07:35, 1 year 1 month ago Sensorion présentera au 60e atelier sur la biologie de l'oreille interne Biotechnologie Thérapie Génique Sensorion Perte Auditive Atelier De Biologie De L'oreille Interne
PRESS RELEASE published on 09/04/2025 at 07:30, 1 year 1 month ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à la 60ème conférence annuelle Inner Ear Biology Workshop pour présenter ses avancées en thérapie génique pour la perte auditive Thérapie Génique Sensorion Perte Auditive Biologie Oreille Interne 60ème Conférence
Published on 10/27/2026 at 01:00, 1 hour 39 minutes ago Mining Exploration Entity or Oil and Gas Exploration Entity Quarterly Cash Flow Report
Published on 10/27/2026 at 00:10, 2 hours 29 minutes ago Trans Canada Gold Closes Final Tranche of Non-Brokered Private Placement for Gross Proceeds of CDN $2,205,737 and Prepares for Phase 2 Drilling
Published on 10/26/2026 at 23:30, 3 hours 9 minutes ago Trans Canada Gold Closes Final Tranche of Non-Brokered Private Placement for Gross Proceeds of CDN $2,205,737 and Prepares for Phase 2 Drilling
Published on 10/26/2026 at 23:00, 3 hours 39 minutes ago American Hotel Income Properties REIT LP to Host Third Quarter 2026 Results Conference Call on November 16, 2026
Published on 10/26/2026 at 22:00, 4 hours 39 minutes ago IBC Advanced Alloys Announces Issuance of Share-Based Compensation to Directors
Published on 10/27/2026 at 01:15, 1 hour 24 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Update on APAC matter
Published on 10/27/2026 at 01:05, 1 hour 33 minutes ago New electrification index shows China out front as US risks stalling and Europe's policies outpace delivery
Published on 10/26/2026 at 22:23, 4 hours 16 minutes ago EQS-Adhoc: SMAG Mobile Antenna Masts AG: Changes to the Management Board
Published on 10/26/2026 at 21:57, 4 hours 41 minutes ago EQS-Adhoc: PAUL Tech AG: Noteholders’ Meeting in respect of the EUR 35 million notes resolves on extension of the term of the notes
Published on 10/26/2026 at 21:32, 5 hours 6 minutes ago UPDATE ON STRATEGIC TRANSACTION, FURTHER PORTFOLIO DISPOSAL PROCESS AND CONTINUED LENDER SUPPORT
Published on 10/26/2026 at 18:11, 8 hours 28 minutes ago Declaration of transactions on own shares from October 19, 2026 to October 25, 2026
Published on 10/26/2026 at 18:11, 8 hours 28 minutes ago Déclaration des transactions sur actions propres réalisées du 19/10/2026 au 25/10/2026
Published on 10/26/2026 at 17:45, 8 hours 54 minutes ago Déclaration hebdomadaire de rachat d'actions
Published on 10/26/2026 at 17:45, 8 hours 54 minutes ago Infotel : Déclaration des transactions sur actions propres réalisées du 19 au 23 octobre 2026 dans le cadre du programme de rachat d’actions.
